心血管生物标志物用于初级预防中的风险分层
Johannes T Neumann1,2,3,4, James A de Lemos5, Fred S Apple6,7,8
1Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg 20246, Germany.
European heart journal
|August 12, 2025
概括
心血管生物标志物可以改善风险评估超越传统因素,帮助预防性心脏病学. 需要进一步的研究,以有效地将这些生物标志物纳入临床实践,以获得更好的患者结果.
科学领域:
- 预防性心脏病学 预防性心脏病学
- 生物标志物发现发现
- 评估心血管风险评估
背景情况:
- 传统的心血管 (CV) 风险因素提供了适度的CV风险预测.
- 目前的风险模型在歧视和校准方面存在局限性.
- 需要改进CV风险评估策略.
研究的目的:
- 审查临床使用理想循环生物标志物的特征.
- 总结关于CV生物标志物的证据,用于风险分层.
- 探索新兴的蛋白质组技术,以提高心血管风险预测.
主要方法:
- 关于CV生物标志物和事件CV事件的研究文献综述.
- 对传统风险模型中添加的生物标志物的增值值的分析.
- 对高通量蛋白质分析的蛋白质组技术的概述.
主要成果:
- 许多研究表明CV生物标志物和CV事件之间存在关联.
- 生物标志物的增量预测价值相对于传统的风险因素往往是温和的.
- 新兴的蛋白质组技术为改善心血管风险预测提供了潜力.
结论:
- 心血管生物标志物可以重新分类风险,特别是在中等风险人群中.
- 生物标志物的临床整合需要进一步的临床试验证据,以证明其成本效益和对CV事件的影响.
- 需要创新和研究,以制定CV预防中常规使用生物标志物的指导方针.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
214
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
334
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55


